240 related articles for article (PubMed ID: 26429665)
21. A20 Attenuates FFAs-induced Lipid Accumulation in Nonalcoholic Steatohepatitis.
Ai L; Xu Q; Wu C; Wang X; Chen Z; Su D; Jiang X; Xu A; Lin Q; Fan Z
Int J Biol Sci; 2015; 11(12):1436-46. PubMed ID: 26681923
[TBL] [Abstract][Full Text] [Related]
22. Dysregulated Autophagy in Hepatocytes Promotes Bisphenol A-Induced Hepatic Lipid Accumulation in Male Mice.
Yang S; Zhang A; Li T; Gao R; Peng C; Liu L; Cheng Q; Mei M; Song Y; Xiang X; Wu C; Xiao X; Li Q
Endocrinology; 2017 Sep; 158(9):2799-2812. PubMed ID: 28323964
[TBL] [Abstract][Full Text] [Related]
23. Autophagy inhibition due to thymidine analogues as novel mechanism leading to hepatocyte dysfunction and lipid accumulation.
Stankov MV; Panayotova-Dimitrova D; Leverkus M; Vondran FW; Bauerfeind R; Binz A; Behrens GM
AIDS; 2012 Oct; 26(16):1995-2006. PubMed ID: 22914580
[TBL] [Abstract][Full Text] [Related]
24. Ursodeoxycholyl lysophosphatidylethanolamide inhibits lipoapoptosis by shifting fatty acid pools toward monosaturated and polyunsaturated fatty acids in mouse hepatocytes.
Chamulitrat W; Liebisch G; Xu W; Gan-Schreier H; Pathil A; Schmitz G; Stremmel W
Mol Pharmacol; 2013 Nov; 84(5):696-709. PubMed ID: 23974795
[TBL] [Abstract][Full Text] [Related]
25. Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids.
Lamaziere A; Wolf C; Barbe U; Bausero P; Visioli F
Prostaglandins Leukot Essent Fatty Acids; 2013 Feb; 88(2):149-54. PubMed ID: 23313470
[TBL] [Abstract][Full Text] [Related]
26. A human hepatocellular in vitro model to investigate steatosis.
Gómez-Lechón MJ; Donato MT; Martínez-Romero A; Jiménez N; Castell JV; O'Connor JE
Chem Biol Interact; 2007 Jan; 165(2):106-16. PubMed ID: 17188672
[TBL] [Abstract][Full Text] [Related]
27. Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy.
Zhang X; Deng Y; Xiang J; Liu H; Zhang J; Liao J; Chen K; Liu B; Liu J; Pu Y
Drug Des Devel Ther; 2020; 14():3393-3405. PubMed ID: 32884242
[TBL] [Abstract][Full Text] [Related]
28. Ghrelin Attenuated Lipotoxicity via Autophagy Induction and Nuclear Factor-κB Inhibition.
Mao Y; Cheng J; Yu F; Li H; Guo C; Fan X
Cell Physiol Biochem; 2015; 37(2):563-76. PubMed ID: 26329041
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Notch1 signaling reduces hepatocyte injury in nonalcoholic fatty liver disease via autophagy.
Zhang M; Wu P; Li M; Guo Y; Tian T; Liao X; Tan S
Biochem Biophys Res Commun; 2021 Apr; 547():131-138. PubMed ID: 33610041
[TBL] [Abstract][Full Text] [Related]
30. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease.
Scorletti E; Byrne CD
Annu Rev Nutr; 2013; 33():231-48. PubMed ID: 23862644
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease.
Malhi H; Gores GJ
Semin Liver Dis; 2008 Nov; 28(4):360-9. PubMed ID: 18956292
[TBL] [Abstract][Full Text] [Related]
32. Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.
Nobili V; Alisi A; Musso G; Scorletti E; Calder PC; Byrne CD
Crit Rev Clin Lab Sci; 2016; 53(2):106-20. PubMed ID: 26463349
[TBL] [Abstract][Full Text] [Related]
33. Saturated fatty acid-mediated endoplasmic reticulum stress and apoptosis are augmented by trans-10, cis-12-conjugated linoleic acid in liver cells.
Wei Y; Wang D; Pagliassotti MJ
Mol Cell Biochem; 2007 Sep; 303(1-2):105-13. PubMed ID: 17426927
[TBL] [Abstract][Full Text] [Related]
34. Lipid storage droplet protein 5 reduces sodium palmitate‑induced lipotoxicity in human normal liver cells by regulating lipid metabolism‑related factors.
Ma X; Cheng F; Yuan K; Jiang K; Zhu T
Mol Med Rep; 2019 Aug; 20(2):879-886. PubMed ID: 31173228
[TBL] [Abstract][Full Text] [Related]
35. Prolonged Lipid Accumulation in Cultured Primary Human Hepatocytes Rather Leads to ER Stress than Oxidative Stress.
Rennert C; Heil T; Schicht G; Stilkerich A; Seidemann L; Kegel-Hübner V; Seehofer D; Damm G
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993055
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease.
Pang L; Liu K; Liu D; Lv F; Zang Y; Xie F; Yin J; Shi Y; Wang Y; Chen D
Cell Death Dis; 2018 Jan; 9(2):90. PubMed ID: 29367738
[TBL] [Abstract][Full Text] [Related]
37. Accumulation of lipids and oxidatively damaged DNA in hepatocytes exposed to particles.
Vesterdal LK; Danielsen PH; Folkmann JK; Jespersen LF; Aguilar-Pelaez K; Roursgaard M; Loft S; Møller P
Toxicol Appl Pharmacol; 2014 Jan; 274(2):350-60. PubMed ID: 24121055
[TBL] [Abstract][Full Text] [Related]
38. Excess fructose and fatty acids trigger a model of non‑alcoholic fatty liver disease progression in vitro: Protective effect of the flavonoid silybin.
Grasselli E; Baldini F; Vecchione G; Oliveira PJ; Sardão VA; Voci A; Portincasa P; Vergani L
Int J Mol Med; 2019 Aug; 44(2):705-712. PubMed ID: 31173180
[TBL] [Abstract][Full Text] [Related]
39. Ghrelin Reduces TNF-α-Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis: Role in Obesity-Associated NAFLD.
Ezquerro S; Mocha F; Frühbeck G; Guzmán-Ruiz R; Valentí V; Mugueta C; Becerril S; Catalán V; Gómez-Ambrosi J; Silva C; Salvador J; Colina I; Malagón MM; Rodríguez A
J Clin Endocrinol Metab; 2019 Jan; 104(1):21-37. PubMed ID: 30137403
[TBL] [Abstract][Full Text] [Related]
40. Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action.
Scorletti E; Byrne CD
Mol Aspects Med; 2018 Dec; 64():135-146. PubMed ID: 29544992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
